Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)
ALNY Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
30.40%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
56.70%
ALNY Stock Analysis
ALNY
PE Ratio:
69.3
ALNY
PEG Ratio:
1.4
ALNY
Forward EPS Growth (12 month):
51.10%
ALNY
PS Ratio:
9.1
ALNY
PSG Ratio:
0.3
ALNY
Forward Revenue Growth (12 month):
31.30%
ALNY Articles
No data was found